Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.94 |
| ▸ | CA1 | P00915 | 3/20 | 0.94 |
| ▸ | CA12 | O43570 | 1/20 | 0.94 |
| ▸ | CA3 | P07451 | 1/20 | 0.94 |
| ▸ | TYR | P14679 | 1/20 | 0.94 |
| ▸ | DRD1 | P21728 | 1/20 | 0.94 |
| ▸ | CA4 | P22748 | 1/20 | 0.94 |
| ▸ | CA6 | P23280 | 1/20 | 0.94 |
| ▸ | CA5A | P35218 | 1/20 | 0.94 |
| ▸ | CA7 | P43166 | 1/20 | 0.94 |
| ▸ | CA9 | Q16790 | 1/20 | 0.94 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.94 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.94 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.80 |
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terephthalic Acid SCHEMBL3460105 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL20500516 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL5311518 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL7622776 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Terephthalic Acid SCHEMBL6692916 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL3212865 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL4110 | 0.97 | CA2 (1.00) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL10725692 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL20815891 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR | |
| Paraben SCHEMBL8921839 | 0.94 | CA2 (0.94) | CA2CA1CA12CA3TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7304182-B2 | Crystalline parahydroxybenzoic acid anhydride and process for preparing the same | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 2007-12-04 | — | — | US | claimed |
| US-20040235725-A1 | Application discloses two newly identified enzymatic activities called pectin transesterase (PTE) and pectin transesterase synthase (PTES) that are responsible for hydrolyzing and synthesizing ester bonds between HG chains of pectin; PTE can be used as additive to modify fluidity of foods and drugs | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2004-11-25 | — | — | US | disclosed |
| WO-2003017950-A2 | METHODS FOR MAKING PECTIN-BASED MIXED POLYMERS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235725-A1 | Application discloses two newly identified enzymatic activities called pectin transesterase (PTE) and pectin transesterase synthase (PTES) that are responsible for hydrolyzing and synthesizing ester bonds between HG chains of pectin; PTE can be used as additive to modify fluidity of foods and drugs | GALE, PRUNE1, MGAM | CA2 1287/4885CA1 1045/4885CA12 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.